What are Cox-2 inhibitors?

Our law firm has been in the forefront of the effort to have all of the cyclooxygenase-2 (COX-2) inhibitors (Bextra, Celebrex, and Vioxx) taken off the market since the law firm took on its first case against Merck more than 6 years ago.

Beasley Allen is spearheading the review of over 31,000 claims against the manufacturers of Bextra, Celebrex, and Vioxx.

One of the most popular in the COX-2 class is Vioxx, used by tens of millions of people worldwide. It was pulled off the market September 30, 2004. This decision came shortly after a medical conference where FDA researcher David Graham showed higher doses of Vioxx correlated with a tripled risk of heart attack or sudden cardiac death compared to people who weren’t taking any similar drug.

Pfizer (the manufacturer of Celebrex and Bextra) suspended sales of their arthritis drug, Bextra, following a recommendation from the FDA. Despite numerous published studies which undeniably link the COX-2 inhibitors to a greater risk of heart-attacks, strokes and even Stevens Johnson Syndrome (SJS), as well as a stern warning from the FDA in December of 2004, Pfizer was unwilling to voluntarily pull its drugs off the market until April 7, 2005.

Following the recall of Bextra, Pfizer continues to manufacture the only remaining COX-2 inhibitor, Celebrex.

What can I do?

If you or a loved one has been diagnosed with a heart attack, stroke, Stevens Johnson Syndrome or other serious side effect as the result of taking a COX-2 inhibitor, you may be entitled to compensation. For a free legal consultation, contact us today!



We're here to help!

We live by our creed of "helping those who need it most" and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked    may be required for submission.
  1. I'm an attorney

End Conflicts on FDA Approvals

In the coming weeks, the U.S. House and Senate will have to reconcile bills they passed that give the...

Frank Woodson on the Additional Costs and Hidden...

Frank Woodson and David Miceli discuss the additional costs and hidden dangers associated with COX-2...

Consumer Group says Celebrex Ad Downplays Risks

Pfizer had stopped advertising for the arthritis drug after Merck & Co. Inc.'s rival drug Vioxx was...

Pharmaceutical Companies put Patients at Risk for...

With the soaring prices of prescription medications, one would hope that the drugs we purchase are...

Merck hid Drug's Risks, Lawyer says in Vioxx Trial

Pharmaceutical giant Merck ignored warnings and tried to cover up risks associated with its blockbuster...

COX-2 Drugs may Raise Risk of Repeat Heart Attack

While Vioxx was pulled from the US market due to an elevated risk of heart attacks and stroke in adults,...

Continuing the battle with Big Pharma

The entire Beasley Allen staff had our personal interest at heart. We were part of the family of a down to earth, trustworthy, understanding law firm. Thank you, Beasley Allen, for continuing the battle with Big Pharma.

—Richard